Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

EADO/WCM 2025 | The evolving role of AI and imaging in melanoma diagnosis and staging

Iris Zalaudek • 3 Apr 2025
EADO/WCM 2025
Melanoma Skin Cancer

Iris Zalaudek, MD, PhD, University of Trieste, Trieste, Italy, highlights the impact of technological advancements in melanoma diagnosis and staging. She discusses the role of AI-supported diagnostics and evolving imaging techniques, such as PET-CT, in improving patient assessment. While progress is being made, the search for reliable biomarkers to predict metastasis remains ongoing. However, with global research efforts intensifying, Prof. Zalaudek anticipates significant advancements in melanoma management over the next decade. This interview took place at the 11th World Congress of Melanoma and 21st EADO Congress in Athens, Greece.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.

More from Iris Zalaudek

Refining follow-up strategies to address overdiagnosis in early-stage melanoma
3:07
Refining follow-up strategies to address overdiagnosis in early-stage melanoma
Iris Zalaudek • 3 Apr 2025
Rethinking melanoma follow-up: patient education over routine imaging
2:09
Rethinking melanoma follow-up: patient education over routine imaging
Iris Zalaudek • 3 Apr 2025
New EADO guidelines
1:04
New EADO guidelines
Iris Zalaudek • 26 Apr 2022
Could locally advanced SCC be treated for a shorter duration in an elderly population?
1:52
Could locally advanced SCC be treated for a shorter duration in an elderly population?
Iris Zalaudek • 26 Apr 2022

Related Videos

BRAF/MEK inhibition prior to immunotherapy in melanoma: insights from the COWBOY trial
1:45
BRAF/MEK inhibition prior to immunotherapy in melanoma: insights from the COWBOY trial
Kalijn Bol • 31 May 2026
COWBOY trial: optimal sequencing of BRAF/MEK inhibition and immunotherapy in BRAF-mutated melanoma
1:08
COWBOY trial: optimal sequencing of BRAF/MEK inhibition and immunotherapy in BRAF-mutated melanoma
Kalijn Bol • 31 May 2026
Could induction BRAF/MEK inhibition be useful for some melanoma patients with metastases?
1:02
Could induction BRAF/MEK inhibition be useful for some melanoma patients with metastases?
Kalijn Bol • 31 May 2026
The future of personalized and off-the-shelf mRNA vaccines in melanoma
1:02
The future of personalized and off-the-shelf mRNA vaccines in melanoma
James Smithy • 31 May 2026
The content of VJOncology is intended for healthcare professionals